Universidad De Almeria
Clinical trials sponsored by Universidad De Almeria, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a common supplement slow Alzheimer's? new trial aims to find out Results expected Sep 2026 (estimated)
-
Morning or evening workout: which melts liver fat best?
Disease control Not yet recruitingThis study looks at whether exercising in the morning or evening makes a bigger difference in reducing liver fat for postmenopausal women with fatty liver disease. Sixty-three women will be placed into morning exercise, evening exercise, or a no-exercise group for 12 weeks. Resea…
Sponsor: Universidad de Almeria • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a common supplement slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThis Phase 3 trial tests whether a daily supplement called tributyrin can slow cognitive decline in people with mild Alzheimer's disease. Over 12 weeks, 156 participants will take either tributyrin or a placebo. Researchers will measure changes in memory, thinking, gut bacteria, …
Phase 3 • Sponsor: Universidad de Almeria • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC